Where Does Reviva Pharmaceuticals Holdings, Inc. (RVPH) Stock Fall in the Biotechnology Field After It Has Fallen -15.57% This Week?

Reviva Pharmaceuticals Holdings, Inc. (RVPH) is around the top of the Biotechnology industry according to InvestorsObserver. RVPH received an overall rating of 67, which means that it scores higher than 67 percent of all stocks. Reviva Pharmaceuticals Holdings, Inc. also achieved a score of 85 in the Biotechnology industry, putting it above 85 percent of Biotechnology stocks. Biotechnology is ranked 46 out of the 148 industries.

RVPH has an Overall Score of 67. Find out what this means to you and get the rest of the rankings on RVPH!

See Full RVPH Report

What do These Ratings Mean?

Trying to find the best stocks can be a daunting task. There are a wide variety of ways to analyze stocks in order to determine which ones are performing the strongest. InvestorsObserver makes the entire process easier by using percentile rankings that allows you to easily find the stocks who have the strongest evaluations by analysts. Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.

What's Happening With Reviva Pharmaceuticals Holdings, Inc. Stock Today?

Reviva Pharmaceuticals Holdings, Inc. (RVPH) stock is higher by 0.39% while the S&P 500 has fallen -0.06% as of 10:42 AM on Friday, Dec 1. RVPH is higher by $0.02 from the previous closing price of $3.83 on volume of 44,925 shares. Over the past year the S&P 500 is higher by 11.98% while RVPH is higher by 8.15%. RVPH lost -$1.67 per share the over the last 12 months. Click Here to get the full Stock Report for Reviva Pharmaceuticals Holdings, Inc. stock.